Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab

Fireside Chats on Endocrinology and Metabolism in the Mantzoros lab

The Mantzoros Lab
Country USA
Language EN
Episodes 10
Latest 30.10.2026

This podcast is hosted by Prof. Christos Mantzoros, assisted by Dr. Laura Valenzuela, at the Mantzoros Lab at Harvard Medical School and Beth Israel Deaconess Medical Center. It shares clinically relevant and scientifically novel information about cutting-edge concepts in endocrinology, diabetes, nutrition, and metabolism. The show also highlights mentorship, innovation, and a shared passion for the endocrine system.

Episodes

  • Thyroid Eye Disease (TED): From Pathophysiology to Diagnosis and Targeted Therapy
    Thyroid Eye Disease (TED): From Pathophysiology to Diagnosis and Targeted Therapy 30.10.2026 25m
    Thyroid eye disease (TED), previously known as Graves orbitopathy / Graves opthalmopathy, is more than an eye condition, and managing it requires more than controlling thyroid function. What drives the autoimmune processes behind TED, how can clinicians recognize it early, and how is our growing understanding of its pathophysiology changing treatment? In this episode we explore the pathophysiology, diagnosis, and evolving management of thyroid eye disease. Together, we unpack the roles of TSH receptor autoantibodies, IGF-1 receptor signaling, and orbital fibroblast activation in driving inflam...
  • The Hidden Cost of Weight Loss Meds: Reevaluating Muscle, Metabolism, and Modern Obesity Treatments
    The Hidden Cost of Weight Loss Meds: Reevaluating Muscle, Metabolism, and Modern Obesity Treatments 24.11.2025 11m
    Current and emergent incretin-based therapies (such as GLP-1 and GIP receptor agonists) have transformed obesity treatment by producing unprecedented weight loss. But these benefits come with complexity: significant lean mass loss, raising concerns about metabolic stability, muscle health, and long-term outcomes. In this episode, we briefly revisit the clinical approach to weight-loss medications, connect the foundations of leptin dysregulation with leptin-independent pathways (including the activin/follistatin/myostatin/IGF-1 system), and link these pathways to energy homeostasis and muscle m...
  • Emerging Pharmacotherapies and Future Perspectives for Obesity Treatment
    Emerging Pharmacotherapies and Future Perspectives for Obesity Treatment 22.01.2024 15m
    Obesity is described by many as the epidemic of the 21st century. Currently, limited and suboptimal drugs are available to the clinician's therapeutic armamentarium. However, novel agents and combination schemes, mainly with Incretin Analogs, seem to be revolutionizing the way we will soon be treating overweight and obesity. In this podcast, we discuss notable drug advancements and concepts of novel agents, the need for metabolism clinics for the interaction of various medical specialties, and bariatric/metabolic surgery in managing individuals with chronic metabolic conditions. There is more...
  • ESPAÑOL: De Hígado Graso No Alcohólico (NAFLD) a Enfermedad Hepática Esteatósica Asociada a Disfunción Metabólica (MASLD)
    ESPAÑOL: De Hígado Graso No Alcohólico (NAFLD) a Enfermedad Hepática Esteatósica Asociada a Disfunción Metabólica (MASLD) 24.10.2023 10m
    Este episodio es la traducción en español de nuestra conversación con el Dr. Christos Mantzoros, profesor y endocrinólogo de la Facultad de Medicina de Harvard, sobre el cambio de la terminología de Hígado Graso No Alcohólico (NAFLD por sus siglas en íngles) hacia la Enfermedad Hepática Esteatósica Asociada a Disfunción Metabólica (MASLD). Además hablaremos de la importancia de esta nueva nomenclatura y sus implicaciones en la clínica y la investigación. El consenso que guió el cambio, hacia a una terminología más precisa y apropiada, está respaldado por los avances en la comprensión de la fis...
  • From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD), an update of the new terminology and its significance
    From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD), an update of the new terminology and its significance 26.08.2023 20m
    In this episode, Dr. Christos Mantzoros, Professor and Endocrinologist at Harvard Medical School and the editor-in-chief of the Journal Metabolism: Clinical and Experimental, will guide the discussion about the ongoing journey towards refining the NAFLD terminology to Steatotic Liver Disease (SLD) and will shed light to the significance of the recent nomenclature change. The consensus to shift to a new, more accurate, and appropriate name is underpinned by the advances in understanding the multisystem and multifactorial pathophysiology of metabolic dysfunction-associated steatotic liver diseas...
  • ESPAÑOL: Lo que debes saber de Obesidad: ¿Qué tan frecuente es la obesidad, cómo desarrollamos la obesidad y por qué es importante?
    ESPAÑOL: Lo que debes saber de Obesidad: ¿Qué tan frecuente es la obesidad, cómo desarrollamos la obesidad y por qué es importante? 02.04.2023 19m
    La obesidad es la epidemia del siglo XXI, pero ¿qué es y por qué la desarrollamos? ¿Es una enfermedad? ¿Existe la obesidad metabólicamente saludable y la no saludable? ¡Bienvenido a la serie sobre la obesidad! En este primer episodio, presentaremos conceptos críticos sobre cómo desarrollamos la obesidad y por qué es importante. ¡Estén atentos de nuestros siguientes episodios de obesidad! Los autores poseen los derechos de autor de todos los contenidos de este Podcast. Reservados todos los derechos. Los usuarios de este Podcast pueden guardar y usar la información contenida en el Podcast solo p...
  • Obesity 101:  How Prevalent Is Obesity, How Do We Develop Obesity, and Why It Matters?
    Obesity 101: How Prevalent Is Obesity, How Do We Develop Obesity, and Why It Matters? 21.02.2023 30m
    Obesity is the global epidemic of the 21st century, but what is it, and why do we develop it? Is it a disease? Is there metabolically healthy and unhealthy obesity? Welcome to the obesity series! In this first episode, we will present critically important concepts on how we develop obesity and why it matters. There is more to come, please stay tuned! The authors own the copyright to all the contents of this Podcast. All rights reserved. Users of this Podcast may save and use the information contained in the Podcast only for personal or other non-commercial purposes. No other use, including, bu...
  • ESPAÑOL: Enfermedad del hígado graso: una necesidad clínica no satisfecha
    ESPAÑOL: Enfermedad del hígado graso: una necesidad clínica no satisfecha 27.01.2023 14m
    La enfermedad del hígado graso no alcohólico (NAFLD, por sus siglas en inglés) es una importante epidemia de salud pública estrechamente relacionada con las epidemias de obesidad y síndrome metabólico. Su prevalencia, combinada con los avances recientes de la investigación, requiere que los endocrinólogos y los médicos de atención primaria participen en la identificación y el manejo de las personas afectadas o en riesgo de desarrollar esta enfermedad. Bienvenidos a nuestro episodio "Enfermedad del hígado graso: una necesidad clínica no satisfecha"; Hay más por venir en nuestro podcast, ¡estén...
  • Fatty Liver Disease: An Unmet Clinical Need
    Fatty Liver Disease: An Unmet Clinical Need 19.10.2022 21m
    Nonalcoholic fatty liver disease (NAFLD) is a major public health epidemic closely linked to the epidemics of obesity and the metabolic syndrome. Its prevalence, combined with recent research advances, necessitates that endocrinologists and primary care physicians are involved in identifying and managing persons affected by, or at risk for developing this disease. Welcome to our episode Fatty Liver Disease: An Unmet Clinical Need; There is more to come, please stay tuned! The authors own the copyright to all the contents of this Podcast. All rights reserved. Users of this Podcast may save and...
  • Español: Introducción ¡Bienvenidos a nuestro Podcast!
    Español: Introducción ¡Bienvenidos a nuestro Podcast! 12.10.2022 4m
    Bienvenidos al primer episodio de nuestro podcast ¡Estamos muy emocionados de que te unas a nosotros! Gracias por estar acá, El Mantzoros Lab, ¡Apasionados por la Endocrinología, la Innovación y la Mentoría!
  • Introduction, Welcome To Our Podcast!
    Introduction, Welcome To Our Podcast! 05.10.2022 4m
    Welcome to the first episode of the Fireside Chats on Endocrinology and Metabolism in the Mantzoros Lab. We are so excited you are joining us! Thank you, The Mantzoros Lab. Passionate about Endocrinology, Innovation, and Mentoring! The following music was used for this media project: Music: Total Happy Up And Sunny by Sascha Ende. License (CC BY 4.0): https://filmmusic.io/standard-license. Artist website: https://www.sascha-ende.de